Möchten Sie immer auf dem neuesten Stand bleiben?

Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability

TAMPA, Fla. and LONDON, March 17, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice...

Preclinical evidence supports azenosertib ADC combinations as potential promising therapeutic strategies for Triple-Negative Breast Cancer  Demonstration of Cyclin E1 protein overexpression as an...

Myriad announces FDA approval for the MyChoice CDx Test as the Companion Diagnostic for Zejula, a PARP inhibitor from GSK, for patients with ovarian cancer

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and...

Q2X, powered by Xendoo, becomes Xero’s preferred migration partner, delivering full historical QuickBooks-to-Xero data migration for businesses.

Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with...

Taipei, Taiwan, March 17, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology...

PARIGI e ATLANTA, March 17, 2026 (GLOBE NEWSWIRE) -- Akur8, la piattaforma leader globale nel mercato attuariale basata sull’intelligenza artificiale, ha annunciato oggi l'acquisizione di Slope...

PARIS and ATLANTA, March 17, 2026 (GLOBE NEWSWIRE) -- Akur8, the leading Global Actuarial AI platform, announced today it has acquired Slope Software, a cloud-native, all-in-one actuarial modeling...